Top compounds associated with response to CT45A1


Feature Type Standardized
Nominal ANOVA
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.048 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.045 0.2
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.057 0.2
mRNA indisulam CTRPv2 pan-cancer AAC -0.042 0.2
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.064 0.2
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV